Open Access · CC BY-NC 4.0
Retraction Notice: “YTHDF1-mediated sphingosine kinase 2 upregulation alleviates bupivacaine-induced neurotoxicity via the PI3K/AKT axis”
Human & Experimental Toxicology · 2026-05 · 45
DOI: 10.1177/09603271261452720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human & Experimental Toxicology, online erschienen am 20.05.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Retraction Notice: “YTHDF1-mediated sphingosine kinase 2 upregulation alleviates bupivacaine-induced neurotoxicity via the PI3K/AKT axis”. Human & Experimental Toxicology, 45. https://doi.org/10.1177/09603271261452720
Vancouver
Retraction Notice: “YTHDF1-mediated sphingosine kinase 2 upregulation alleviates bupivacaine-induced neurotoxicity via the PI3K/AKT axis”. Human & Experimental Toxicology. 2026;45. doi:10.1177/09603271261452720
BibTeX
@article{euvimed2026,
title = {Retraction Notice: “YTHDF1-mediated sphingosine kinase 2 upregulation alleviates bupivacaine-induced neurotoxicity via the PI3K/AKT axis”},
journal = {Human & Experimental Toxicology},
year = {2026},
volume = {45},
doi = {10.1177/09603271261452720}
}
EUVIMED